12.4 CMM Services, CPT Coding (99605-99607) & Practice Management
Key Takeaways
- Comprehensive Medication Management (CMM) is a standardized, patient-centered clinical practice standard wherein the clinical pharmacist systematically assesses every medication for indication, effectiveness, safety, and adherence, formulating a collaborative care plan with the interprofessional team.
- Pharmacist-specific CPT codes for MTM/CMM include CPT 99605 (initial 15 minutes, new patient face-to-face), CPT 99606 (initial 15 minutes, established patient face-to-face), and CPT 99607 (add-on for each additional 15 minutes), billed according to the AMA midpoint rule.
- Medicare Part B "Incident-To" physician billing (E/M codes 99211–99215) permits auxiliary staff (including clinical pharmacists) to provide clinical services billed under a supervising physician's NPI, requiring direct physician supervision (physical presence in the office suite), an established patient, and a physician-initiated plan of care.
- Additional Medicare care management billing pathways utilized by ambulatory care pharmacists include Chronic Care Management (CCM: CPT 99490 for ≥20 minutes non-face-to-face monthly care for ≥2 chronic conditions), Principal Care Management (PCM), and Annual Wellness Visits (AWV: G0438 initial, G0439 subsequent).
- Establishing ambulatory pharmacy services requires a detailed business plan with pro forma financial models balancing hard-dollar direct billing against soft-dollar value-based returns (shared savings, readmission penalties avoided, MIPS bonuses), clinic space logistics, EHR integration, and institutional credentialing and clinical privileging.
CMM Services, CPT Coding & Practice Management
Executive Summary: Sustainable ambulatory clinical pharmacy services depend upon mastering clinical practice standards, healthcare reimbursement mechanisms, and practice management operations. Comprehensive Medication Management (CMM) defines the clinical standard of care for optimizing pharmacotherapy. To ensure financial sustainability, clinical pharmacists navigate diverse billing frameworks—including Pharmacist CPT codes (99605–99607), Medicare Part B "Incident-To" E/M billing (99211–99215), Chronic Care Management (CCM CPT 99490), and Annual Wellness Visits (AWV G0438/G0439). Furthermore, clinical pharmacy leaders must develop structured business plans, construct pro forma financial projections, calculate Return on Investment (ROI), and navigate credentialing and privileging pathways within health systems.
1. Comprehensive Medication Management (CMM) Standards
As defined by the Patient-Centered Primary Care Collaborative (PCPCC) and the American College of Clinical Pharmacy (ACCP), Comprehensive Medication Management (CMM) is the standard of care that ensures each patient's medications (whether prescription, nonprescription, alternative, traditional, vitamins, or dietary supplements) are individually assessed to determine that each medication is:
- Appropriate for the medical condition being treated (Indication)
- Effective for achieving clinical and personal goals of therapy (Effectiveness)
- Safe given the comorbidities and other medications being taken (Safety)
- Able to be taken by the patient as intended (Adherence)
THE FOUR PILLARS OF CMM ASSESSMENT
+-----------------------------------------------------------------------------------------+
| 1. INDICATION | Does every medication have a valid clinical indication? |
| | Is there an untreated indication requiring new GDMT therapy? |
+--------------------------+--------------------------------------------------------------+
| 2. EFFECTIVENESS | Is the medication achieving therapeutic target goals (e.g., |
| | BP <130/80 mmHg, HbA1c <7.0%, LDL-C reduction ≥50%)? |
+--------------------------+--------------------------------------------------------------+
| 3. SAFETY | Are there active adverse drug events, drug interactions, |
| | contraindications, organ toxicities, or supratherapeutic doses?|
+--------------------------+--------------------------------------------------------------+
| 4. ADHERENCE | Is the patient willing and able to take the medication as |
| | prescribed? Are there financial, physical, or cognitive gaps?|
+-----------------------------------------------------------------------------------------+
Distinguishing CMM from MTM and Disease State Management
| Practice Characteristic | Medication Therapy Management (MTM) | Disease State Management (DSM) | Comprehensive Medication Management (CMM) |
|---|---|---|---|
| Primary Driver | Medicare Part D statutory mandate; payer-centric. | Clinic protocol focused on a single condition. | Standardized clinical care process; patient-centric. |
| Scope of Assessment | Often targeted to high drug spend or discrete drug list. | Narrow focus on one disease (e.g., Anticoagulation or Diabetes only). | Holistic evaluation of ALL medical conditions and ALL medications. |
| Care Team Integration | Frequently telephonic, disconnected from primary care EHR. | Clinic-based, but isolated to specialty silo. | Directly embedded in primary care / specialty team with shared EHR. |
| Prescriptive Authority | Recommendations sent via fax to prescriber. | Protocol-driven titration for single condition. | Direct regimen adjustment via CPA or collaborative team consensus. |
| Longitudinal Follow-up | Annual review; episodic. | Condition-specific follow-up. | Continuous, longitudinal care until therapeutic goals are achieved. |
2. Pharmacist CPT Billing Codes (99605, 99606, 99607)
The American Medical Association (AMA) established pharmacist-specific Current Procedural Terminology (CPT) codes to describe face-to-face medication therapy management and CMM services rendered by a licensed pharmacist.
Code Definitions
- CPT 99605: Medication therapy management service(s) provided by a pharmacist, individual, face-to-face with patient, with assessment and intervention if provided; initial 15 minutes, new patient.
- CPT 99606: Medication therapy management service(s) provided by a pharmacist, individual, face-to-face with patient, with assessment and intervention if provided; initial 15 minutes, established patient.
- CPT 99607: Medication therapy management service(s) provided by a pharmacist, individual, face-to-face with patient, with assessment and intervention if provided; each additional 15 minutes, list separately in addition to code for primary service. (Add-on code used in conjunction with 99605 or 99606).
The AMA Midpoint Rule for Time-Based Billing
Under AMA CPT guidelines, a unit of time is attained when the midpoint is passed. For 15-minute time-based increments, a minimum of 8 minutes must be completed to bill the first or additional unit:
AMA MIDPOINT TIME-BASED BILLING RULES
+-----------------------+-----------------------------------------------+-----------------+
| Face-to-Face Duration | Established Patient Billing Codes | Total Units |
+-----------------------+-----------------------------------------------+-----------------+
| 1 to 7 minutes | Not billable under CPT time rules | 0 units |
| 8 to 22 minutes | 99606 | 1 unit (99606) |
| 23 to 37 minutes | 99606 + 99607 | 2 units (1 base, 1 add-on)|
| 38 to 52 minutes | 99606 + 99607 x 2 | 3 units (1 base, 2 add-on)|
| 53 to 67 minutes | 99606 + 99607 x 3 | 4 units (1 base, 3 add-on)|
| 68 to 82 minutes | 99606 + 99607 x 4 | 5 units (1 base, 4 add-on)|
+-----------------------+-----------------------------------------------+-----------------+
Payer Landscape Note: CPT codes 99605–99607 are accepted and reimbursed by commercial health plans, state Medicaid programs, and self-insured employer health plans in states recognizing pharmacist provider status. However, traditional Medicare Part B does NOT currently recognize 99605–99607 for direct pharmacist fee-for-service reimbursement because pharmacists are not enumerated as independent practitioners under Section 1861(s) of the Social Security Act.
3. Medicare Part B "Incident-To" Physician Billing & E/M Codes
To bill Medicare Part B for ambulatory clinical pharmacy services provided in physician clinics, health systems utilize "Incident-To" billing under Section 1861(s)(2)(A) of the Social Security Act. Services are billed under the supervising physician's National Provider Identifier (NPI).
The Five Mandatory Conditions for Incident-To Billing
FIVE MANDATORY INCIDENT-TO CRITERIA
+-----------------------------------------------------------------------------------------+
| 1. DIRECT SUPERVISION | The supervising physician must be PHYSICALLY PRESENT in |
| | the office suite and immediately available to assist. |
| | (Off-site or phone supervision is strictly prohibited). |
+------------------------------+----------------------------------------------------------+
| 2. ESTABLISHED PATIENT | The patient must be an established patient of the clinic |
| | who has previously had a face-to-face physician visit. |
+------------------------------+----------------------------------------------------------+
| 3. PHYSICIAN PLAN OF CARE | The physician must have established the initial diagnosis|
| | and initiated the active plan of care being managed. |
+------------------------------+----------------------------------------------------------+
| 4. EMPLOYMENT / CONTRACT | The pharmacist must be an employee, leased employee, or |
| | contracted auxiliary staff of the billing physician/group|
+------------------------------+----------------------------------------------------------+
| 5. WITHIN SCOPE OF PRACTICE | The clinical service performed must fall within the |
| | legal scope of state pharmacy practice and clinic bylaws.|
+-----------------------------------------------------------------------------------------+
Evaluation and Management (E/M) Coding Levels
- CPT 99211 (Level 1 E/M Office Visit):
- Known as the "minimal visit" or "nurse visit" code.
- Office or other outpatient visit for the evaluation and management of an established patient that may not require the presence of a physician or other qualified health care professional (QHP).
- Does not require specific Medical Decision-Making (MDM) complexity thresholds.
- Reimbursed at approximately $20–$30 per encounter.
- Most universally accepted code for pharmacist incident-to billing across all Medicare Administrative Contractors (MACs).
- CPT 99212–99215 (Levels 2–5 E/M Office Visits):
- Higher complexity established patient visits requiring straightforward (99212), low (99213), moderate (99214), or high (99215) MDM complexity.
- Billing Mechanism: In collaborative team-based care models, pharmacists perform the comprehensive clinical assessment, drug titration, and documentation, followed by the physician entering the exam room to evaluate the patient, review the plan, and finalize medical decision-making (billing 99213–99215 under physician work).
Other Value-Based Medicare Billing Pathways
-
Chronic Care Management (CCM - CPT 99490):
- Reimburses non-face-to-face care management furnished to patients with $\ge 2$ chronic conditions expected to last $\ge 12$ months that place the patient at significant risk of death, acute exacerbation, or functional decline.
- Requirement: At least 20 minutes of qualifying clinical staff time per calendar month directed by a physician/QHP under general supervision.
- Activities: Telephonic medication reconciliation, dose titration follow-ups, coordinating lab testing, prescription refill management.
-
Annual Wellness Visits (AWV):
- HCPCS G0438: Initial Annual Wellness Visit (first AWV, once in a lifetime).
- HCPCS G0439: Subsequent Annual Wellness Visit (annually thereafter).
- Pharmacist Execution: Pharmacists can furnish the entire AWV under direct or general physician supervision, administering the Health Risk Assessment (HRA), screening for depression (PHQ-9) and cognitive impairment (Mini-Cog), reviewing medical/family history, performing comprehensive medication reconciliation, and establishing a 5-to-10-year personalized preventative care plan.
4. Practice Management: Business Plans, Pro Forma, ROI & Privileging
Establishing, sustaining, and expanding an ambulatory clinical pharmacy service requires rigorous clinical practice management leadership.
1. Developing the Ambulatory Pharmacy Business Plan
A structured business plan justifies resource allocation to health system executives. It contains five core sections:
- Executive Summary: High-level problem statement, proposed clinical pharmacy solution, required investment, and projected clinical/financial returns.
- Clinical Service Description: Detailed scope of services (e.g., CMM primary care embed, transitions-of-care clinic, specialized heart failure GDMT optimization), patient eligibility criteria, referral pathways, and CPA structure.
- Market & Gap Analysis: Assessment of health system chronic disease burden (e.g., 3,200 attributed patients with uncontrolled diabetes), HEDIS/Star Rating deficits, readmission penalty vulnerabilities, and provider burnout rates.
- Operational Plan: Staffing model (FTE allocation), physical clinic exam space scheduling, medical assistant support, EHR documentation templates, and clinical workflow integration.
- Financial Projections & Pro Forma Modeling: 3-to-5-year financial forecast detailing direct revenue, operating expenses, cost avoidance, and return on investment.
2. Pro Forma Financial Modeling & ROI Mathematics
PRO FORMA ANNUAL REVENUE & COST PROFILE
+-----------------------------------------------------------------------------------------+
| A. HARD-DOLLAR DIRECT REVENUE |
| * CPT 99211 Incident-To Billing (1,200 visits/year @ $25/visit) = $30,000 |
| * Annual Wellness Visits (300 AWVs/year @ $120/visit [G0439]) = $36,000 |
| * Chronic Care Management (150 patients x 12 months @ $40/month [99490]) = $72,000 |
| * Commercial CMM CPT 99606/99607 Billing (400 visits/year @ $75/visit) = $30,000 |
| ===> Subtotal Hard Revenue = $168,000 |
+-----------------------------------------------------------------------------------------+
| B. SOFT-DOLLAR VALUE-BASED RETURNS & COST AVOIDANCE |
| * Hospital Readmission Reductions (15 readmissions avoided @ $14,000/stay) = $210,000 |
| * ACO Shared Savings / MIPS Quality Bonus Payment Capture = $85,000 |
| * ED Diversions (40 avoidable visits diverted @ $1,500/visit) = $60,000 |
| ===> Subtotal Soft Savings = $355,000 |
+-----------------------------------------------------------------------------------------+
| C. TOTAL ANNUAL PROGRAM VALUE (A + B) = $523,000 |
+-----------------------------------------------------------------------------------------+
| D. ANNUAL OPERATING EXPENSES (1.0 FTE Clinical Pharmacist) |
| * Pharmacist Base Salary ($130,000) + Fringe Benefits @ 28% ($36,400) = $166,400 |
| * Clinic Overhead, Workspace, Software Licenses, IT Integration = $15,000 |
| ===> Total Annual Operating Cost = $181,400 |
+-----------------------------------------------------------------------------------------+
| NET FINANCIAL BENEFIT (C - D) = $341,600 |
| RETURN ON INVESTMENT (ROI) = ($341,600 / $181,400) x 100% = 188.3% (or ~2.9 : 1 ROI) |
+-----------------------------------------------------------------------------------------+
3. Credentialing and Clinical Privileging
To practice at the top of their professional license within an institutional health system, clinical pharmacists must complete formal credentialing and privileging through the Medical Staff Office:
- Credentialing: The formal process of verifying professional education (ACPE-accredited PharmD), active state licensure, postgraduate residency training (ASHP-accredited PGY1/PGY2), board certification (BPS BCACP), and malpractice claims history (via the National Practitioner Data Bank [NPDB]).
- Clinical Privileging: The process whereby the hospital/health system Medical Executive Committee (MEC) and Governing Board grant specific clinical practice authorities to the pharmacist (e.g., independent prescriptive authority under CPA, ordering diagnostic and monitoring laboratory tests, initiating dose titrations, performing physical assessments, and ordering medical equipment).
A clinical pharmacist in an ambulatory endocrine clinic conducts a comprehensive face-to-face follow-up encounter with an established patient with type 2 diabetes and hypertension. The visit includes a full medication reconciliation, review of continuous glucose monitoring data, titration of basal insulin, addition of empagliflozin, and ordering renal function labs. The total face-to-face encounter time spent with the patient is exactly 40 minutes. Under AMA CPT time-based midpoint rules, which of the following CPT coding combinations should be billed for this established patient visit?
An ambulatory care pharmacist embedded in a family medicine clinic provides chronic disease medication management. The clinic bills Medicare Part B for these encounters under the "Incident-To" physician billing framework (CPT 99211). Which of the following scenarios represents a direct violation of Medicare Part B Incident-To billing regulations?
A clinical pharmacy coordinator is drafting a pro forma financial model to establish a new ambulatory clinical pharmacy service in a health system primary care network. Which of the following value propositions accurately articulates the comprehensive Return on Investment (ROI) of the proposed service to health system leadership?